CanSERV has extended the deadline for its first call for services on “Advancing Personalised Medecine” until May 25th. Cancer Researchers in, and outside the EU are invited to apply for free access to cutting-edge transnational services with an indicative overall budget of EUR 500,000.
The aim of this call is to accelerate knowledge gain in personalised oncology with specific emphasis on multi-level data-based treatment guidance linked to Molecular Tumour Boards.
The projects supported under this call will support the advance and implementation of personalized medicine strategies for all cancer patients in Europe, contributing to the overarching goals of the Cancer Mission Board.
CanSERV is now calling for experts to participate in populating the European Molecular Tumour Board Network.
The European Network for Personalised Oncology (ENPO) aims to provide state-of-the-art guidance and support to accelerate the implementation of personalised oncology. Anyone involved in a Molecular Tumor Board (MTB) – e.g., physicians, scientists, patient representatives, ethicists – is welcome to join the European Network for Personalised Oncology (ENPO) and its European Molecular Tumor Board Network (EMTBN).
At MMCI was designed 3D printer drawing of nasopharyngeal (sampling swabs) and printed the plastic base of the sampling stick on 3D printer from PETG material.
Bank of Biological Materials at Masaryk Memorial Cancer institute (BBM MMCI) significantly contributed to the research focused on the development of a new sensitive diagnostic method for the detection of early-stage pancreatic cancer.